Search results for "stable angina"

showing 10 items of 89 documents

Serum brain-derived neurotrophic factor and platelet activation evaluated by soluble P-selectin and soluble CD-40-ligand in patients with acute myoca…

2009

Little is known about the role of neurotrophins (NT) under adult vascular homeostasis in normal and pathological conditions. The NT family, including nerve growth factor and brain-derived neurotrophic factor (BDNF) are expressed in atherosclerotic vessels. Previous studies demonstrated that plasma BDNF levels were increased in the coronary circulation in patients with unstable angina. However, the role of BDNF during the onset and evolution of unstable angina remains to be elucidated. The objective of this study was to evaluate the relationship between BDNF, functional parameters and biological markers associated with inflammatory processes and platelet activation. BDNF serum levels were as…

PharmacologyBrain-derived neurotrophic factor0303 health sciencesmedicine.medical_specialtyP-selectinUnstable anginabusiness.industry030204 cardiovascular system & hematologymedicine.disease03 medical and health sciencesCoronary circulation0302 clinical medicineNerve growth factorEndocrinologymedicine.anatomical_structureNeurotrophic factorsInternal medicineImmunologymedicinePharmacology (medical)Platelet activationMyocardial infarctionbusiness030304 developmental biologyFundamental & Clinical Pharmacology
researchProduct

Thrombolysis plus heparin versus heparin alone in the acute phases of unstable angina: preliminary findings

1995

Abstract Several studies have shown conflicting effects of thrombolysis in patients with unstable angina. In these trials the time between presentation with chest pain and randomization was long (12 hours to 3 days). This study compared thrombolysis and heparin with heparin-alone treatment in patients in the acute phase of unstable angina. One hundred fifty-three consecutive patients hospitalized with chest pain at rest (first episode) lasting >5 minutes but P = 0.013). Data suggest that thrombolysis plus heparin produces faster clinical stabilization than heparin alone in patients treated during the acute phase of unstable angina.

PharmacologyFirst episodemedicine.medical_specialtyRandomizationT-plasminogen activatorbusiness.industrymedicine.drug_classUnstable anginamedicine.medical_treatmentAnticoagulantHeparinThrombolysisChest painmedicine.diseaseSurgeryAnesthesiamedicinePharmacology (medical)medicine.symptombusinessmedicine.drugCurrent Therapeutic Research
researchProduct

New developments in IL-6 dependent biology and therapy: where do we stand and what are the options?

2005

Interleukin-6 (IL-6) is a four-helical protein which, on target cells, binds to a specific IL-6-receptor and two molecules of the promiscuous signal transducing protein gp130. Structure-function analysis defined three molecular contact sites between IL-6 and its receptor subunits. Using this information, competitive antagonistic proteins as well as hyperagonistic proteins were developed. Possible therapeutic applications of IL-6 antagonists are in IL-6 dependent haematological disorders (Castleman's disease, POEMS syndrome, multiple myeloma) and bone diseases (Paget's disease, osteoporosis). Designer IL-6 antagonists could suppress inflammatory activity in rheumatic and autoimmune diseases …

PharmacologySystemic lupus erythematosusbiologybusiness.industryUnstable anginamedicine.medical_treatmentGlomerulonephritisGeneral Medicinemedicine.diseaseGlycoprotein 130CytokineImmunologymedicinebiology.proteinPharmacology (medical)businessInterleukin 6ReceptorMultiple myelomaExpert opinion on investigational drugs
researchProduct

Moderne Therapie bei akutem Koronarsyndrom

2002

Inhibition of platelet aggregation with aspirin and anticoagulation with unfractionated heparin can be considered the gold standard treatment of patients with acute coronary syndromes. Replacement of unfractionated heparins by low-molecular weight heparins seem to further improve the cardiovascular risk. Additional treatment with glycoprotein IIb/IIIa receptor blockers led to a further reduction of the clinical event rate, especially in patients undergoing coronary interventions during an acute coronary syndrome (more than 30% relative risk reduction). However, the latter substances did only lead to marginal improvements in the setting of a conservative stabilization of patients with acute …

Relative risk reductionAcute coronary syndromeAspirinmedicine.medical_specialtybusiness.industryUnstable anginaGeneral Medicinemedicine.diseaseClopidogrelCoronary artery diseaseAnginaInternal medicineCardiologyMedicineMyocardial infarctionbusinessmedicine.drugMedizinische Klinik
researchProduct

Guideline-adherence and perspectives in the acute management of unstable angina - Initial results from the German chest pain unit registry.

2015

Abstract Background We investigated the current management of unstable angina pectoris (UAP) in certified chest pain units (CPUs) in Germany and focused on the European Society of Cardiology (ESC) guideline-adherence in the timing of invasive strategies or choice of conservative treatment options. More specifically, we analyzed differences in clinical outcome with respect to guideline-adherence. Method Prospective data from 1400 UAP patients were collected. Analyses of high-risk criteria with indication for invasive management and 3-month clinical outcome data were performed. Guideline-adherence was tested for a primarily conservative strategy as well as for percutaneous coronary interventi…

Risk profilingMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentMedizinCardiologyChest painPatient AdmissionPercutaneous Coronary InterventionRisk FactorsInternal medicineGermanymedicineHumansAcute managementAngina UnstableProspective StudiesRegistriesAgedGuideline adherenceUnstable anginabusiness.industryPercutaneous coronary interventionDisease ManagementGuidelineMiddle Agedmedicine.diseaseConventional PCIEmergency medicinePractice Guidelines as TopicPhysical therapyCardiologyGuideline Adherencemedicine.symptombusinessCardiology and Cardiovascular MedicineHospital UnitsJournal of cardiology
researchProduct

Estratificación del riesgo de pacientes con dolor torácico sin elevación del segmento ST en la puerta de urgencias

2003

Objectives. To investigate the prognostic factors in patients who come to the emergency room with chest pain but without ST segment elevation. Patients and method. 743 consecutive patients were evaluated by recording clinical history, electrocardiogram and troponin I determination, and early (< 24 h) exercise testing was done for the low-risk subgroup of patients (n = 203). All patients were followed during 3 months for major events (acute myocardial infarction or death). Results. Major events occurred in 71 patients (9.6%). Multivariate analysis (C stadistic = 0.79; 95% CI 0.730.84; p = 0.0001) identified the following predictors: age ≥ 72 years (OR = 1.7; 95% CI, 1.0-2.9; p = 0.05), insul…

ST depressionmedicine.medical_specialtyFramingham Risk Scorebusiness.industryUnstable anginaOdds ratiomedicine.diseaseChest painSurgeryInternal medicineTroponin ImedicineCardiologyST segmentMyocardial infarctionmedicine.symptomCardiology and Cardiovascular MedicinebusinessRevista Española de Cardiología
researchProduct

Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicente…

2017

The aim of this study was to report on the midterm outcomes of patients undergoing percutaneous coronary intervention with bioresorbable vascular scaffolds (BVS) for the treatment of acute coronary syndromes (ACS) and compare with those of patients with stable coronary artery disease (sCAD).One thousand four hundred and seventy-seven (1,477) patients underwent implantation of one or more BVS (Absorb BVS; Abbott Vascular, Santa Clara, CA, USA) at 11 European centres and were included in the GHOST-EU registry. Admissions comprised 47.1% of the patients (951 BVS) with ACS, and 52.8% (1,274 BVS) with sCAD. During a median follow-up of 384 (359-460) days, patient-oriented endpoints (PoCE), inclu…

Target lesionMaleAcute coronary syndromemedicine.medical_specialtymedicine.medical_treatmentInfarctionCoronary Artery Disease030204 cardiovascular system & hematologyCoronary artery disease03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionInternal medicineMedicineHumans030212 general & internal medicineRegistriesAcute Coronary SyndromeAgedRetrospective StudiesTissue Scaffoldsbusiness.industryUnstable anginaIncidence (epidemiology)Percutaneous coronary interventionMiddle Agedmedicine.diseaseThrombosisTreatment OutcomeCardiologyFemaleCardiology and Cardiovascular MedicinebusinessEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
researchProduct

Rational and design of the European randomized Optical Coherence Tomography Optimized Bifurcation Event Reduction Trial (OCTOBER)

2018

Background Percutaneous coronary intervention in complex bifurcation lesions is prone to suboptimal implantation results and is associated with increased risk of subsequent clinical events. Angiographic ambiguity is high during bifurcation stenting, but it is unknown if procedural guidance by intravascular optical coherence tomography (OCT) improves clinical outcome. Methods and design OCTOBER is a randomized, investigator-initiated, multicenter trial aimed to show superiority of OCT-guided stent implantation compared to standard angiographic-guided implantation in bifurcation lesions. The primary outcome measure is a 2-year composite end point of cardiac death, target lesion myocardial inf…

Target lesionMalemedicine.medical_specialtyBiolääketieteet - Biomedicinemedicine.medical_treatment030204 cardiovascular system & hematologyCoronary AngiographyLesion03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionMulticenter trialmedicineHumans030212 general & internal medicineMyocardial infarctionTomographyAgedUnstable anginabusiness.industrySisätaudit - Internal medicineCoronary StenosisPercutaneous coronary interventionStentDrug-Eluting StentsMiddle Agedmedicine.diseaseCoronary VesselsStenosisTreatment OutcomeOptical CoherenceSettore MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREFemaleRadiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessTomography Optical CoherenceAmerican Heart Journal
researchProduct

Supervised Analysis for Phenotype Identification: The Case of Heart Failure Ejection Fraction Class

2021

Artificial Intelligence is creating a paradigm shift in health care, with phenotyping patients through clustering techniques being one of the areas of interest. Objective: To develop a predictive model to classify heart failure (HF) patients according to their left ventricular ejection fraction (LVEF), by using available data from Electronic Health Records (EHR). Subjects and methods: 2854 subjects over 25 years old with a diagnosis of HF and LVEF, measured by echocardiography, were selected to develop an algorithm to predict patients with reduced EF using supervised analysis. The performance of the developed algorithm was tested in heart failure patients from Primary Care. To select the mo…

Technologymedicine.medical_specialtyphenotypeQH301-705.5heart failureBioengineering030204 cardiovascular system & hematologyArticleprimary care03 medical and health sciences0302 clinical medicineText miningLasso (statistics)Internal medicinemedicine030212 general & internal medicineMyocardial infarctionBiology (General)Cluster analysisEjection fractionbusiness.industryUnstable anginaTallergologyleft ventricular ejection fractionAtrial fibrillationartificial intelligencemedicine.disease3. Good healthRandom forestHeart failureCardiologysupervised analysisbusiness
researchProduct

''High-Intensity Interval Training in Cardiac Rehabilitation''

2012

Guiraud, Thibaut | Nigam, Anil | Gremeaux, Vincent | Meyer, Philippe | Juneau, Martin | Bosquet, Laurent; International audience; ''High-intensity interval training (HIIT) is frequently used in sports training. The effects on cardiorespiratory and muscle systems have led scientists to consider its application in the field of cardiovascular diseases. The objective of this review is to report the effects and interest of HIIT in patients with coronary artery disease (CAD) and heart failure (HF), as well as in persons with high cardiovascular risk. A non-systematic review of the literature in the MEDLINE database using keywords 'exercise', 'high-intensity interval training', 'interval training'…

[SCCO.NEUR] Cognitive science/NeuroscienceSTEADY-STATE EXERCISERANDOMIZED CONTROLLED-TRIALSTEADY-STATE EXERCISE''CHRONIC HEART-FAILUREPRACTICE GUIDELINES COMMITTEEQUALITY-OF-LIFECHRONIC STABLE ANGINA[ SCCO.NEUR ] Cognitive science/NeuroscienceCORONARY-ARTERY-DISEASESHORT INTERMITTENT RUNSASSOCIATION TASK-FORCE''CHRONIC HEART-FAILURECONTINUOUS MODERATE EXERCISE
researchProduct